OTP 10 - Take-Home Privileges for Unsupervised Use of Medication
The organization establishes criteria to determine when take-home privileges can become part of an individual’s service plan and how medications are provided in accordance with applicable federal regulations concerning the prescription and distribution of controlled substances.
Direct service personnel, medical and other appropriate personnel, service recipients, and, whenever possible, family members, participate in determining if the individual meets criteria for take-home medication.
To support the initiation of take-home privileges, the medical director considers:
Interpretation: “Other special needs" may include, and are not limited to, emergency circumstances, split dosing, and pain treatment.
Interpretation: All elements should be considered collectively in determining whether take home privileges are appropriate for an individual. Decisions should not be based solely on toxicology test reports.
For each person provided with take-home medication, the organization:
related OTP 9
The medical director uses established criteria to decide when take-home medication is contraindicated, including:
Individuals receive guidance on how to safely secure take-home medication.
Interpretation: The medical director considers whether the medication can be safely stored in the person’s place of residence when determining if the individual may be permitted unsupervised use of medication.
Take-home medication is prohibited for individuals receiving short-term detoxification or interim maintenance treatment.
NA The organization does not provide short-term detoxification or interim maintenance treatment.
The organization labels take-home medication with the organization’s name, address, and telephone number.
related RPM 3
Note: See also Risk Prevention and Management for standards regarding Medication Control and Administration.